Responders’ immune profiles also revealed a higher presence of myeloid dendritic cell subtypes DC1 and DC2 (Fig. S2D) [17], suggesting that these specific dendritic cell populations may play a pivotal role in augmenting T cell anti-tumor activity. The gene discussed is ZDHHC4; the disease is neoplasm.